🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/12/2020 | 148,85 | 151,44 | 147,99 | 150,00 | +0,11% | 2,32% | 250.300 |
| 24/12/2020 | 150,23 | 151,44 | 149,52 | 149,83 | +0,31% | 1,28% | 117.000 |
| 23/12/2020 | 146,47 | 150,33 | 145,46 | 149,36 | +2,06% | 3,32% | 344.100 |
| 22/12/2020 | 146,31 | 147,20 | 144,43 | 146,35 | +0,15% | 1,89% | 376.800 |
| 21/12/2020 | 145,96 | 146,88 | 143,35 | 146,13 | -0,49% | 2,42% | 252.000 |
| 18/12/2020 | 149,07 | 150,60 | 145,25 | 146,85 | -1,07% | 3,59% | 907.300 |
| 17/12/2020 | 146,46 | 148,80 | 146,25 | 148,44 | +1,50% | 1,74% | 335.500 |
| 16/12/2020 | 148,87 | 149,00 | 145,72 | 146,25 | -1,32% | 2,20% | 425.200 |
| 15/12/2020 | 144,37 | 148,47 | 143,34 | 148,21 | +3,54% | 3,55% | 401.600 |
| 14/12/2020 | 140,00 | 146,24 | 139,58 | 143,14 | +3,20% | 4,76% | 382.300 |
| 11/12/2020 | 137,21 | 139,25 | 131,04 | 138,70 | +1,09% | 5,98% | 216.000 |
| 10/12/2020 | 134,89 | 138,31 | 133,32 | 137,21 | +1,90% | 3,70% | 224.700 |
| 09/12/2020 | 135,58 | 136,82 | 132,71 | 134,65 | -0,32% | 3,03% | 289.100 |
| 08/12/2020 | 131,70 | 135,46 | 129,64 | 135,08 | +3,92% | 4,42% | 541.300 |
| 07/12/2020 | 133,44 | 133,91 | 129,43 | 129,98 | -2,61% | 3,36% | 247.300 |
| 04/12/2020 | 130,49 | 134,13 | 130,04 | 133,47 | +2,72% | 3,13% | 309.200 |
| 03/12/2020 | 132,06 | 132,71 | 129,46 | 129,94 | -1,02% | 2,46% | 365.200 |
| 02/12/2020 | 132,09 | 132,09 | 130,61 | 131,28 | -0,91% | 1,12% | 275.600 |
| 01/12/2020 | 132,95 | 133,97 | 132,43 | 132,49 | -0,11% | 1,16% | 323.300 |
| 30/11/2020 | 135,34 | 136,98 | 131,96 | 132,64 | -2,14% | 3,71% | 547.200 |
| 27/11/2020 | 134,60 | 135,85 | 134,29 | 135,54 | +0,35% | 1,16% | 113.300 |
| 25/11/2020 | 135,34 | 138,00 | 134,91 | 135,07 | -0,27% | 2,28% | 210.700 |
| 24/11/2020 | 138,49 | 138,49 | 135,40 | 135,43 | -1,70% | 2,23% | 198.100 |
| 23/11/2020 | 137,01 | 138,03 | 135,18 | 137,77 | +1,29% | 2,08% | 254.200 |
| 20/11/2020 | 136,20 | 137,99 | 134,74 | 136,02 | -0,48% | 2,39% | 401.400 |
| 19/11/2020 | 139,55 | 139,55 | 135,28 | 136,67 | -0,59% | 3,06% | 284.400 |
| 18/11/2020 | 142,14 | 142,17 | 137,38 | 137,48 | -2,57% | 3,37% | 303.900 |
| 17/11/2020 | 142,49 | 142,49 | 139,70 | 141,11 | -1,27% | 1,96% | 426.900 |
| 16/11/2020 | 142,52 | 144,26 | 141,45 | 142,93 | +1,02% | 1,97% | 335.500 |
| 13/11/2020 | 141,18 | 141,80 | 140,17 | 141,48 | +1,08% | 1,15% | 247.300 |